Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page's revision label changed from v3.6.5 to v3.6.6, signaling a new version of the page. This update reflects a content or metadata refresh rather than a user-facing feature change.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 in the page footer, indicating a newer page revision. This reflects an internal update rather than a substantive change to the page content.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a newer release version of the page or its underlying system. This reflects a maintenance/version update rather than changes to visible content.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision tag at the bottom of the page updated from v3.6.2 to v3.6.3, reflecting a new version of the page.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a newer release. This reflects a minor update or bug fix rather than a change to study details or user-facing content.SummaryDifference0.1%

- Check83 days agoChange DetectedNew navigation items were added for How to Read a Study Record, Common Questions, and How to Join a Study, and the Intervention/Treatment label was introduced. The old Intervention / Treatment label and the prior revision note (v3.5.5) were removed.SummaryDifference0.5%

Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.